CTRI/2011/091/000034已完成4 期
An open-label, randomized, prospective study to evaluate the efficacy and safety of conversion to Sirolimus (Rapacan) based regimen from Calcineurin Inhibitors based regimen in maintenance kidney transplant recipients - Rapacan Trial
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •Men and women renal transplant recipients >= 18yrs old
- •ï?· Undergone denovo live donor renal transplantation >= 3 months prior to enrollment
- •ï?· Receiving CNI based regimen after transplantation
- •ï?· Serum creatinine <= 2.5mg/dl and Proteinuria <=800mg/day
排除标准
- •Pregnant, nursing mothers or women of childbearing potential without an effective method of birth control.
- • Renal transplant recipients who had episodes of acute rejection, delayed graft failure or signs of graft failure
- • Patients suffering from any malignancy requiring immediate surgery, ongoing chemotherapy or radiation
- • Patients suffering from any acute systemic infections within 30 days prior to enrollment
- • Use of any investigational drug upto 4 weeks prior to enrolling in the study
- • Patients requiring second renal transplantation or Multiple organ transplantation
- • Patients having any other systemic disease which may aggravate or prevent him to undergo immunosuppression
研究者
相似试验
尚未招募
3 期
Saroglitazar and Fenofibrate in diabetic dyslipidemiaCTRI/2021/03/031900Endolife Specialty Hospital
进行中（未招募）
1 期
A randomised, open label, prospective study to assess two different therapeutic strategies following first treatment failure in HIV-1 infected subjects. ‘The First Failure Study’ : ‘FAST’ - The First Failure StudyHIVEUCTR2009-011816-39-GBImperial College London44
已完成
不适用
Clinical Trial to investigate the Safety and Efficacy of the BugSpeaks based personalized diet on the patients with Hyperglycemia and Hyperlipidemia.CTRI/2022/05/042791eucine Rich Bio Pvt Ltd60
招募中
4 期
Comparison of AgFix® foam dressing versus standard gauze dressing in treatment of grade II pressure ulcers.CTRI/2022/12/047886Dynamic Techno Medicals Private Limited
进行中（未招募）
不适用
An open label, randomized, controlled study to evaluate the safety and efficacy of aerosolized surfactant, Curosurf®, delivered via nasal continuous positive airway pressure pulmonary drug delivery system (NCPAP PDDS) in infants with respiratory distress syndrome.The medical condition for this application is the Respiratory Distress Syndrome (RDS). RDS, also known as hyaline membrane disease, is characterized by lung immaturity and surfactant deficiency and is the most common respiratory disorder in premature infants. The first clinical manifestations of RDS at birth are grunting respiration, subcostal and intercostal retractions, cyanosis and nasal flaring.EUCTR2005-000489-37-CZektar Therapeutics20